Hala

Pandanus tectorius contains phenolics, flavonoids, saponins, terpenoids, and steroids that exert antioxidant activity via DPPH and hydroxyl radical scavenging, anti-inflammatory effects through inhibition of LPS-induced nitric oxide production in macrophages, and wound-healing promotion by upregulating TGF-β-mediated epithelial proliferation. In preclinical models, optimized phenolic-rich fruit extracts achieved DPPH IC50 values of 76.4 μg/mL, floral extracts yielded the highest total phenolic content at 346.65 ± 0.30 mg/g GAE, and topical gel formulations at 20–30% concentration significantly increased tissue regeneration versus untreated controls (p<0.05) in animal wound-healing studies.

Origin & History

Pandanus tectorius, commonly called hala or screw pine, is native to coastal and lowland tropical regions of the Pacific Islands, Southeast Asia, and Australia, thriving in sandy, saline, and seasonally flooded soils from sea level to approximately 600 meters elevation. The species is extensively distributed across Micronesia, Polynesia, and Melanesia, where it grows as a distinctive branching tree with prop roots, long sword-like leaves, and large aggregate fruit heads. Traditionally cultivated and harvested by Pacific Islander communities for food, fiber, medicine, and cultural purposes, the plant requires full sun and tolerates coastal exposure, making it a keystone species in Pacific agroforestry systems.

Historical & Cultural Context

Pandanus tectorius holds profound cultural, nutritional, and medicinal significance across Pacific Island civilizations, with documented use in Micronesian, Polynesian, and Melanesian traditions spanning centuries if not millennia, where virtually every part of the plant—roots, trunk, leaves, flowers, and fruits—served distinct purposes from food and weaving to ritual and healing. In traditional Micronesian and Polynesian medicine, the aerial prop roots were specifically applied to treat mouth ulcers and other oral mucosal conditions, a practice consistent with the plant's demonstrated antibacterial and anti-inflammatory phytochemical profile, though the exact mechanisms were understood empirically rather than biochemically. Fruit drupes, known as keys or segments, were consumed as a staple food across many atolls, particularly in the Marshall Islands and Kiribati where alternative food sources were scarce, while the long fibrous leaves were woven into mats, baskets, sails, and roof thatch central to material culture. The hala tree also carries ceremonial importance in Hawaiian and other Polynesian cultures, appearing in oral traditions, chants, and as a symbol of interconnectedness and passage, reinforcing its role as one of the most culturally integrated plants in the Pacific botanical repertoire.

Health Benefits

- **Antioxidant Activity**: Phenolics and flavonoids in Pandanus tectorius fruit and floral extracts scavenge DPPH and hydroxyl radicals, with optimized fruit extracts reaching IC50 values of 76.4 μg/mL (DPPH) and 62.5 μg/mL (hydroxyl radical), and ethyl acetate fruit core extracts achieving IC50 of 0.8 ± 0.20 mg/mL in DPPH assays.
- **Anti-inflammatory Effects**: Saponin-enriched fruit extracts suppress LPS-stimulated nitric oxide production in RAW 264.7 macrophages, indicating inhibition of pro-inflammatory macrophage activation pathways relevant to conditions including oral ulcers and wound inflammation.
- **Wound Healing and Tissue Regeneration**: Flavonoids and phenolics in fruit extracts upregulate transforming growth factor-beta (TGF-β), promoting epithelial cell proliferation and collagen synthesis; topical gels at 20–30% extract concentration demonstrated statistically significant tissue regeneration in animal models (p<0.05 versus controls).
- **Antibacterial Properties**: Fruit key extracts produced inhibition zones of 10–15 mm against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, with phenolics, flavonoids, and steroids implicated in disrupting bacterial membrane integrity and growth kinetics.
- **Oral Mucosal and Ulcer Relief**: Micronesian and Polynesian traditional medicine employs root preparations topically for mouth ulcers, a use plausibly supported by the combined anti-inflammatory and antibacterial activities of root-derived phenolic and flavonoid compounds, though direct clinical evidence remains absent.
- **Low Cytotoxicity Safety Margin**: Across multiple human-derived cell lines including MCF-7, HeLa, HepG2, L-6, and RAW 264.7 macrophages, most Pandanus tectorius extracts exhibit IC50 values exceeding 30 μg/mL, confirming a favorable safety window at concentrations associated with bioactive effects.
- **Broad-Spectrum Phytochemical Richness**: Floral extracts contain exceptionally high total flavonoid content (143.29 ± 0.22 mg/g QE) alongside TPC of 346.65 ± 0.30 mg/g GAE, while ethanol fruit extracts yield flavonoids at 169.48 mg/mL and terpenoids at 12.76 mg/mL, providing a multi-compound basis for diverse therapeutic applications.

How It Works

Phenolic compounds and flavonoids serve as the primary antioxidant agents in Pandanus tectorius, donating hydrogen atoms or electrons to neutralize DPPH and hydroxyl radicals through standard radical scavenging chemistry, with phenolics identified as the dominant contributors to total antioxidant capacity measured by GAE equivalents. Flavonoids additionally stimulate wound repair by upregulating transforming growth factor-beta (TGF-β) signaling, which drives fibroblast activation, extracellular matrix deposition, and epithelial cell proliferation essential to mucosal and cutaneous healing. Saponin-rich fractions inhibit lipopolysaccharide (LPS)-induced nitric oxide (NO) synthesis in RAW 264.7 macrophages, likely through suppression of inducible nitric oxide synthase (iNOS) expression or upstream NF-κB pathway modulation, though the precise molecular target has not been definitively characterized. Antibacterial steroids, phenolics, and flavonoids are proposed to disrupt bacterial membrane function and interfere with growth kinetics across both gram-positive and gram-negative organisms, though detailed enzyme-level targets such as DNA gyrase or cell-wall biosynthesis enzyme inhibition have not yet been specified in published research.

Scientific Research

Available evidence for Pandanus tectorius is entirely preclinical, comprising in vitro phytochemical screening, cell-based bioassays, and a small number of animal studies, with no published human clinical trials identified in the literature to date. In vitro studies have used RAW 264.7 macrophage, MCF-7, HeLa, HepG2, and L-6 cell lines to assess cytotoxicity and anti-inflammatory activity, demonstrating generally non-cytotoxic profiles (IC50 >30 μg/mL) for most extracts and NO inhibition for saponin-enriched fractions, though sample sizes and replication details are incompletely reported. One in vivo animal wound-healing study evaluated fruit extract gel at 20% and 30% concentrations against untreated controls, finding statistically significant tissue regeneration improvement (p<0.05 versus baseline) with no significant difference between the two active concentrations (p=0.717), but lacking specific effect sizes, histological quantification, and details on animal species or group sizes. The overall evidence base is characterized by methodological heterogeneity, variable extract preparation protocols, and absence of pharmacokinetic or dose-escalation data, placing confidence in therapeutic claims at a preliminary preclinical level.

Clinical Summary

No human clinical trials investigating Pandanus tectorius for any indication have been reported in accessible literature, precluding any evidence-based clinical recommendations. The most structured preclinical evidence comes from an animal wound-healing experiment using fruit extract gel formulations at 20% and 30% concentrations, which demonstrated statistically significant improvement in tissue regeneration compared to untreated controls (p<0.05), though no numerical effect sizes, histopathological scoring systems, or confidence intervals were reported. Antioxidant potency has been quantified across multiple assay systems—with DPPH IC50 values ranging from 0.8 mg/mL to 76.4 μg/mL depending on extraction solvent and tissue source—providing internally consistent in vitro benchmarks, but these cannot be directly extrapolated to human therapeutic doses without pharmacokinetic bridging studies. The current clinical summary is therefore limited to preclinical signals of antioxidant, anti-inflammatory, antibacterial, and wound-healing activity, with confidence in human efficacy remaining low pending controlled trial evidence.

Nutritional Profile

Pandanus tectorius fruits contain appreciable carbohydrates and dietary fiber in the fleshy drupe segments, with traditional consumption contributing caloric energy in atoll diets where the fruits were dried and ground into flour or eaten raw. Phytochemically, ethanol fruit extracts are dominated by flavonoids (approximately 169.48 mg/mL), terpenoids (12.76 mg/mL), and alkaloids (12.24 mg/mL), while saponins are present in smaller quantities (0.053 mg/mL by ethanol extraction but enriched in targeted solvent fractions). Total phenolic content varies substantially by plant part and extraction method, peaking in floral extracts at 346.65 ± 0.30 mg/g GAE and remaining significant in fruit cores and keys; total flavonoid content reaches 143.29 ± 0.22 mg/g QE in flowers. Steroids, triterpenoids, and glycosides are identified qualitatively across fruit, leaf, and root tissues, contributing to the broad phytochemical diversity, though macro- and micronutrient data (minerals, vitamins, amino acids) specific to Pandanus tectorius are not comprehensively characterized in available scientific literature, and bioavailability of specific phenolic fractions remains unstudied in humans.

Preparation & Dosage

- **Topical Gel (Preclinical)**: Fruit extract formulated at 20–30% concentration in a gel base demonstrated wound-healing activity in animal studies; no equivalent human dose has been established.
- **Ethanol Extract (Research)**: Crude ethanol fruit extracts used in phytochemical and bioassay studies contain flavonoids at approximately 169.48 mg/mL, terpenoids at 12.76 mg/mL, and alkaloids at 12.24 mg/mL; no standardized supplemental dose exists.
- **Ethyl Acetate Extract (Research)**: Fruit core ethyl acetate extracts exhibiting antioxidant IC50 of 0.8 ± 0.20 mg/mL (DPPH) have been used in vitro but have no established oral dosage form.
- **Optimized Phenolic-Rich Extract**: Extraction-optimized preparations achieved DPPH IC50 of 76.4 μg/mL and hydroxyl radical IC50 of 62.5 μg/mL; used at research-grade concentrations only.
- **Floral Extract**: Fresh or dried flowers yielded TPC of 346.65 mg/g GAE and TFC of 143.29 mg/g QE in laboratory preparations; no commercial standardization has been established.
- **SNEDDS Leaf Formulation**: A self-nanoemulsifying drug delivery system (SNEDDS) prepared from leaf material was reported to improve bioactivity in one study, but specific dose, bioavailability enhancement data, and commercial availability are not established.
- **Traditional Root Preparation**: Pacific Island traditions use root decoctions or direct root application for oral ulcers; no standardized preparation volume, frequency, or duration has been documented in scientific literature.

Synergy & Pairings

Pandanus tectorius extracts have not been formally studied in combination with other ingredients, but the concurrent presence of flavonoids and phenolics within its own extracts represents an internal synergy, as flavonoids amplify phenolic antioxidant capacity through complementary radical scavenging mechanisms while also contributing TGF-β-mediated wound-healing activity that phenolics alone do not directly provide. In traditional Pacific healing practice, hala root preparations were often used alongside other anti-inflammatory plants endemic to the region, suggesting empirically recognized combination potential, though no documented ethnobotanical stack formulations with named co-ingredients have been scientifically validated. Based on mechanistic complementarity, combination with known wound-healing agents such as Centella asiatica (madecassoside for collagen synthesis) or curcumin (NF-κB inhibition for anti-inflammation) could theoretically enhance the anti-inflammatory and tissue-regeneration profile of Pandanus tectorius topical formulations, though this remains speculative without experimental data.

Safety & Interactions

Pandanus tectorius extracts are described as generally safe at low to moderate concentrations, with most crude and fractionated preparations showing IC50 values exceeding 30 μg/mL across RAW 264.7, L-6, MCF-7, HeLa, and HepG2 cell lines, and the plant is characterized as readily available, inexpensive, and low-risk for topical application in the wound-healing literature. A notable exception involves high-saponin-enriched fruit extract fractions, which demonstrated cytotoxicity with cell survival dropping to approximately 64.3%, indicating that saponin concentration must be monitored in any concentrated extract preparation, and further morphological cytotoxicity studies have been recommended by researchers. No human adverse event reports, drug interaction studies, or contraindication data are available in the published literature, and guidance for pregnancy, lactation, pediatric populations, or individuals with liver or kidney disease cannot be derived from current evidence. Given the complete absence of human pharmacokinetic and toxicological data, any internal use of concentrated Pandanus tectorius extracts should be approached with caution, particularly preparations enriched in saponin fractions, and clinical guidance should await formal safety evaluation.